DB16520ExperimentalProtein Based Therapies
COVID-19 Spike-GM-CSF Protein Lactated Ringer's Injection is an intradermal injection currently being investigated in the clinical trial NCT03348670 (Discovery Stage (Proof-of-concept) COVID-19 Antigen Presentation Therapeutic Biologics (COVID-19--AP) (AP-TP-Bio)) .
- Also known as
- COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection
- Code names
- COVID-19 Spike-GM-CSF Protein Lactated Ringer's Injection
What you can answer from here — as of August 01, 2025
Which companies are running trials of COVID-19 Spike-GM-CSF Protein Lactated Ringer's Injection, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account